Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $29,760 | $105,010 | $103,752 | $29,313 |
| - Cash | $19 | $60 | $105 | $159 |
| + Debt | $60 | $63 | $187 | $186 |
| Enterprise Value | $29,801 | $105,012 | $103,834 | $29,340 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$26 | -$509 | -$571 | -$1,469 |
| % Margin | – | – | – | – |
| Net Income | $547 | $1,210 | $905 | $2,781 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.18 | 0.09 | 0.067 | 0.21 |
| % Growth | 100.2% | 33.6% | -68% | – |
| Operating Cash Flow | -$391 | -$45 | -$54 | -$140 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$391 | -$45 | -$54 | -$140 |